Skip to main content
SpringerLink
Log in

The late-phase inflammatory response after drug-eluting stent implantation

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Recent advances in drug-eluting stent (DES) technology have succeeded in preventing restenosis. In addition to inhibiting smooth muscle cell proliferation, DES greatly inhibits the local inflammatory response in the acute phase after implantation, leading to prevention of restenosis. However, a unique issue in DES implantation is an impairment of reendothelialization, which may result in abnormal wound healing. Consequently, a late-phase inflammatory relapse could appear in the long term after DES implantation. In this study, we measured serum levels of inflammatory markers, including interleukin (IL)-6, IL-8, tumor necrosis factor-α, monocyte chemoattractant protein-1, matrix metalloproteinase-9, and myeloperoxidase, as well as high-sensitivity C-reactive protein at follow-up coronary angiography (mean 9 months) in 54 patients who received DES stenting who did not experience restenosis, and compared them with 51 patients receiving bare-metal stents (BMS) without restenosis. The level of IL-6 was over the measurement threshold (≥2.22 pg/ml) in 12 patients (21 %) in the DES group, but in only 2 patients (4 %) in the BMS group (P = 0.003). IL-8 was significantly higher in the DES group than in the BMS group (4.51 ± 2.40 vs 3.84 ± 1.34 pg/ml, P = 0.015). The levels of other biomarkers were similar between the two groups. DES showed an increase in inflammatory cytokines in the late phase after implantation in comparison with patients who received BMS, suggesting late-stage inflammation. Therefore, the wound-healing response after DES implantation might be different from that after BMS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR (1996) Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 98:2277–2283

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Costa M, Simon D (2005) Molecular basis of restenosis and drug-eluting stents. Circulation 111:2257–2273

    Article  PubMed  Google Scholar 

  3. Inoue T, Node K (2009) Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 73:615–621

    Article  CAS  PubMed  Google Scholar 

  4. Inoue T, Croce K, Morooka T, Sakuma M, Node K, Simon DI (2011) Vascular inflammation and repair: implication for reendothelialization, restenosis, and stent thrombosis. J Am Coll Cardiol Interv 4:1057–1066

    Article  Google Scholar 

  5. Suzuki T, Kopia G, Hayashi S, Bailey L, Llanos G, Wilensky R, Klugherz B, Papandreou G, Narayan P, Leon M, Yeung A, Tio F, Tsao P, Falotico R, Carter A (2001) Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104:1188–1193

    Article  CAS  PubMed  Google Scholar 

  6. Webster MW, Ormiston JA (2007) Drug-eluting stents and late stent thrombosis. Lancet 370:914–915

    Article  PubMed  Google Scholar 

  7. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109:701–705

    Article  PubMed  Google Scholar 

  8. Rifai N, Tracy RP, Ridker PM (1999) Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45:2136–2141

    CAS  PubMed  Google Scholar 

  9. Carson RT, Vignali DA (1999) Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods 227:41–52

    Article  CAS  PubMed  Google Scholar 

  10. de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT (2003) Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 10:133–139

    PubMed Central  PubMed  Google Scholar 

  11. Inoue T, Sata M, Hikichi Y, Sohma R, Fukuda D, Uchida T, Shimizu M, Komoda H, Node K (2007) Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation 115:553–561

    Article  PubMed  Google Scholar 

  12. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R (2005) Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112:270–278

    Article  CAS  PubMed  Google Scholar 

  13. Joner M, Finn AV, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R (2006) Pathology of drug-eluting stent in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:203–205

    Article  Google Scholar 

  14. Watanabe Y, Asano R, Hata N, Inoue K, Takamisawa H, Seki A, Aikawa M, Tobaru T, MIsu K, Iguchi N, Nagayama M, Watanabe H, Takayama M, Umemura J, Sumiyoshi T (2009) Late stent malapposition with marked positive vascular remodeling observed only at the site of drug-eluting stents after multivessel coronary stenting. Heart Vessels 24:308–312

    Article  PubMed  Google Scholar 

  15. Abe S, Yoneda S, Kanaya T, Oda K, Nishino S, Kageyama M, Taguchi I, Masawa N, Inoue T (2012) Pathological features of in-stent restenosis after sirolimus-eluting stent vs. bare metal stent placement. Cardiovasc Pathol 21:e19–e22

    Article  PubMed  Google Scholar 

  16. Yoneda S, Abe S, Kanaya T, Oda K, Nishino S, Kageyama M, Taguchi I, Masawa N, Inoue T (2013) Late phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation. Coronary Artery Dis (in press)

  17. Otsuka Y, Nakamura M, Kokubu N, Tonooka N, Inoue K, Higami T (2012) Diffuse in-stent restenosis of CYPHER® stent due to hypersensitivity reaction confirmed by pathohistological findings. Heart Vessels 27:110–113

    Article  PubMed  Google Scholar 

  18. Yano H, Horinaka S, Yagi H, Ishimitsu T (2013) Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in patients on hemodialysis. Heart Vessels. doi:10.1007/s00380-012-0250-9

    Google Scholar 

  19. Yoneda S, Abe S, Taguchi I, Masawa N, Inoue K, Inoue T (2012) Inflammation and impaired wound healing after zotarolimus-eluting stent implantation. Cardiovasc Pathol 21:511–514

    Google Scholar 

  20. Castell JV, Gomez-Lechon MJ, David M, Hirano T, Kishimoto T, Heinrich PC (1988) Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 232:347–350

    Article  CAS  PubMed  Google Scholar 

  21. Lindmark E, Diderholm E, Wallentin L, Siegbahn A (2001) Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 286:2107–2113

    Article  CAS  PubMed  Google Scholar 

  22. Woodward M, Rumley A, Welsh P, Macmahon S, Lowe GD (2007) A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease. J Thromb Haemost 5:1795–1800

    Article  CAS  PubMed  Google Scholar 

  23. Yue TL, Wang X, Sung CP, Olson B, McKenna PJ, Gu JL, Feuerstein GZ (1994) Interleukin-8, a mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 75:1–7

    Article  CAS  PubMed  Google Scholar 

  24. Inoue T, Komoda H, Nonaka M, Kameda M, Uchida T, Node K (2008) Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol 124:319–325

    Article  PubMed  Google Scholar 

  25. Rattazzi M, Puato M, Faggin E, Bertipaglia B, Zambon A, Pauletto P (2003) C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? J Hypertens 21:1787–1803

    Article  CAS  PubMed  Google Scholar 

  26. Jug B, Salobir BG, Vene N, Šebeštjen M, Šabovič M, Keber I (2009) Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure. Heart Vessels 24:271–276

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi Mibu, Tochigi, 321-0293, Japan

    Isao Taguchi, Shuichi Yoneda, Shichiro Abe, Shigeru Toyoda, Takahisa Nasuno, Setsu Nishino, Michiya Kageyama, Michiaki Tokura, Mikie Ogawa & Teruo Inoue

  2. Department of Cardiovascular Medicine, Saga University, Saga, Japan

    Koichi Node

Authors
  1. Isao Taguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shuichi Yoneda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shichiro Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shigeru Toyoda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takahisa Nasuno
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Setsu Nishino
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michiya Kageyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michiaki Tokura
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mikie Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Koichi Node
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Teruo Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Isao Taguchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taguchi, I., Yoneda, S., Abe, S. et al. The late-phase inflammatory response after drug-eluting stent implantation. Heart Vessels 29, 213–219 (2014). https://doi.org/10.1007/s00380-013-0357-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-013-0357-7

Keywords

Search

Navigation